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Objective: To investigate the ability of cell-laden bilayered hydrogels encapsulating chondrogenically and
osteogenically (OS) pre-differentiated mesenchymal stem cells (MSCs) to effect osteochondral defect
repair in a rabbit model. By varying the period of chondrogenic pre-differentiation from 7 (CG7) to 14
days (CG14), the effect of chondrogenic differentiation stage on osteochondral tissue repair was also
investigated.
Methods: Rabbit MSCs were subjected to either chondrogenic or osteogenic pre-differentiation, encap-
sulated within respective chondral/subchondral layers of a bilayered hydrogel construct, and then
implanted into femoral condyle osteochondral defects. Rabbits were randomized into one of four groups
(MSC/MSC, MSC/OS, CG7/OS, and CG14/OS; chondral/subchondral) and received two similar constructs
bilaterally. Defects were evaluated after 12 weeks.
Results: All groups exhibited similar overall neo-tissue ﬁlling. The delivery of OS cells when compared to
undifferentiated MSCs in the subchondral construct layer resulted in improvements in neo-cartilage
thickness and regularity. However, the addition of CG cells in the chondral layer, with OS cells in the
subchondral layer, did not augment tissue repair as inﬂuenced by the latter when compared to
the control. Instead, CG7/OS implants resulted in more irregular neo-tissue surfaces when compared to
MSC/OS implants. Notably, the delivery of CG7 cells, when compared to CG14 cells, with OS cells stim-
ulated morphologically superior cartilage repair. However, neither osteogenic nor chondrogenic pre-
differentiation affected detectable changes in subchondral tissue repair.
Conclusions: Cartilage regeneration in osteochondral defects can be enhanced by MSCs that are chon-
drogenically and osteogenically pre-differentiated prior to implantation. Longer chondrogenic pre-
differentiation periods, however, lead to diminished cartilage repair.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.: A.G. Mikos, Department of
42, Houston, TX 77251-1892,
: F.K. Kasper, Department of
42, Houston, TX 77251-1892,
sper@rice.edu (F.K. Kasper).
ternational. Published by Elsevier LIntroduction
Articular cartilage is a well-studied ﬂexible connective tissue
that facilitates the tribological interaction of bones in major dia-
rthrodial joints throughout the body. Despite its seemingly simple
structure, the avascular nature of cartilage compromises its
endogenous capacity for repair, leading to a high incidence of un-
resolved cartilage-related injuries1,2. Given the lack of a surgicaltd. All rights reserved.
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nomic burden on society3. However, signiﬁcant research advances
over the years have allowed for the sophistication of conventional
reparative clinical procedures such as marrow stimulation tech-
niques, leading to measurable improvement in patient out-
comes4e7. Yet, these techniques are contraindicated for larger
critical sized lesions, where cell-based regenerative procedures
including autologous chondrocyte transplantation (ACT) or matrix-
assisted ACT often prove more effective3,8. Nevertheless, modern
generation ACT techniques are still unable to obviate signiﬁcant
clinical hurdles involving joint arthroﬁbrosis, limited donor chon-
drocyte availability and donor site morbidity.
Articular chondrocytes, being the constituent cell type of native
articular cartilage, still represent the standard cell source consid-
ered for cell-based cartilage therapies. However, given limited
donor supply, mesenchymal stem cells (MSCs) are becoming
increasingly coveted as an alternative cell source. Their phenotypic
plasticity and renewability make MSCs ideal candidates for the
development of new therapies for osteochondral tissue repair.
Indeed, the delivery of undifferentiated MSCs to osteochondral
defect sites generally confers some therapeutic value9e16. However,
inconsistencies in efﬁcacy challenge such undirected approaches as
viable clinical treatment options17e20, and suggest that ideal con-
ditions for unlocking the full healing potential of MSCs still remain
largely unknown.
Emerging cell-based strategies for osteochondral tissue regen-
eration are increasingly recognizing the importance of cellular
differentiation state and its inﬂuence on treatment outcomes. In
particular, it was recently shown that MSCs chondrogenically pre-
differentiated with transforming growth factor-b3 (TGF-b3) for 14
days outperformed undifferentiated MSCs and even articular
chondrocytes when implanted with a collagen scaffold into an
ovine chronic defect model21. However, other efforts aiming to
leverage the curative properties of chondrogenically pre-
differentiated MSCs failed to elicit improved cartilage tissue
repair over undifferentiated MSCs22,23, indicating that the strategy
for pre-differentiation still requires extensive optimization. Toward
this effort, our laboratory recently evaluated the chondrogenic and
osteogenic capacity of bilayered cell-laden constructs developed
using MSCs that have undergone various degrees of pre-differen-
tiation24. It was found that MSCs subjected to shorter chondrogenic
pre-differentiation periods, when co-cultured with osteogenically
pre-differentiated cells, exhibited greater chondrogenic potential as
indicated by higher glycosaminoglycan (GAG)-to-collagen syn-
thetic ratios in vitro24.
Using a similar oligo(poly(ethylene glycol) fumarate) (OPF)-
based hydrogel system25,26, the present study investigates the
ability of these cell-laden constructs to effect osteochondral tissue
regeneration in vivo. Accordingly, we hypothesized that the de-
livery of osteogenically pre-differentiated cells in a spatially
controlled manner within the subchondral layer of a single bilay-
ered construct would elicit improved histological tissue repair
when compared to scaffolds containing only undifferentiated
MSCs. It is also hypothesized that the prior chondrogenic pre-
differentiation of MSCs encapsulated within the chondral layer
with OS cells in the subchondral layer would further enhance
osteochondral repair depending on the degree of chondrogenic
pre-differentiation. Speciﬁcally, the objectives of the study were
(1) tomeasure the effect of osteogenic pre-differentiation of cells in
the subchondral layer, (2) to evaluate the additional effects of
chondrogenic pre-differentiation of cells in the chondral layer, and
(3) to assess the inﬂuence of chondrogenic pre-differentiation
duration of the cells in the chondral layer on key histological
markers of osteochondral tissue repair in vivo using a rabbit defect
model.Materials and methods
Experimental design
As outlined in Table I, four experimental groups were designed
to address the objectives of this study. Brieﬂy, undifferentiated
MSCs or MSCs chondrogenically pre-differentiated for 7 (CG7) or 14
days (CG14) were encapsulated with osteogenically pre-
differentiated MSCs (OS cells) within respective chondral and
subchondral hydrogel layers of the bilayered hydrogel system. The
MSC/MSC group was utilized as the experimental control.
OPF synthesis and characterization
OPF macromers were synthesized using poly(ethylene
glycol) (PEG) with a nominal molecular weight of 35,000 g/mol
(SigmaeAldrich, St. Louis, MO) following previously established
methods25. The synthesized OPF was characterized using gel
permeation chromatography and stored at20C under N2(g) until
use. Prior to use, the polymer was sterilized by ethylene oxide (EO)
exposure for 12 h following established procedures27.
Gelatin microparticle (GMP) fabrication
GMPs were fabricated using acidic gelatin of a 5.0 isoelectric
point (Nitta Gelatin INC., Osaka, Japan) following well-established
methods28. Prior to hydrogel encapsulation, sterilized GMPs of
50e100 mm in diameter were swollen in phosphate buffered saline
(PBS) (55 mL of PBS per 11 mg of dried GMPs) to achieve swelling
according to previously established procedures29. GMPs were
incorporated into hydrogels to provide moieties for cellematerial
interactions and to aid hydrogel degradation30.
Rabbit marrow MSC isolation and culture
All experimental and surgical protocols for this study were
reviewed and approved by the Rice University and The University of
Texas Health Science Center Institutional Animal Care and Use
Committees (IACUC), and performed according to the National In-
stitutes of Health animal care and use guidelines. Rabbit bone
marrow-derived MSCs were harvested from the tibiae of six 6-
month old New Zealand white rabbits as previously described30.
The isolated bone marrow was cultured in general medium (GM)
containing low glucose Dulbecco's modiﬁed Eagle's medium (LG-
DMEM), 10% v/v fetal bovine serum (FBS), and 1% v/v penicillin/
streptomycin/fungizone (PSF) for 2 weeks. The rabbit marrow-
derived MSCs were then pooled to minimize interanimal varia-
tion and cryopreserved until use as previously described24.
Pre-differentiation of MSCs
Cryopreserved cells were thawed and expanded in monolayer
(3,500 cells/cm2) in GM before pre-differentiation. The various cell
populations used in this study were derived according to a recent
study from our laboratory24. Accordingly, in order to generate cell
populations at varying stages of chondrogenic pre-differentiation,
MSCs were ﬁrst expanded for 2 weeks and then subjected to
either 7 (CG7) or 14 (CG14) days of pre-differentiation in serum-
free chondrogenic media containing LG-DMEM, ITS þ Premix
(6.25 mg/mL insulin, 6.25 mg/mL transferrin, 6.25 mg/mL selenious
acid, 5.35 mg/mL linoleic acid, 1.25 mg/mL bovine serum albumin)
(BD Biosciences, San Jose, CA), 50 mg/L ascorbic acid, 107 M
dexamethasone, 10 ng/mL TGF-b3 (PeproTech, Rocky Hill, NJ), and
1% v/v PSF. It was shown previously that 7 and 14 days of chon-
drogenic pre-differentiation using this method led to the
Table I
Cell-laden bilayered hydrogel design for the four formulations evaluated in this study. For each group, six animals were used
Experimental groups MSC/MSC
(12 implants)
MSC/OS
(12 implants)
CG7/OS
(12 implants)
CG14/OS
(12 implants)
OPF hydrogel precursor solution
Cartilage layer
(Top 1 mm)
10 mM GMPs mg per 100 mg OPF 22 22 22 22
Cell Suspension Cell population MSC MSC CG7 CG14
CG pre-differentiation duration
(Before Encapsulation)
0 days 0 days 7 days 14 days
Encapsulation density
(million per mL precursor)
10 10 10 10
Subchondral layer
(Bottom 2 mm)
10 mM GMPs mg per 100 mg OPF 22 22 22 22
Cell Suspension Cell population MSC OS OS OS
OS pre-differentiation duration
(Before Encapsulation)
0 days 6 days 6 days 6 days
Encapsulation density
(million per mL precursor)
10 10 10 10
Description
Black Circles: GMPs
White: Undifferentiated MSCs
Pink: Osteogenic Cells
Light Green: Chondrogenic Cells (7 days)
Dark Green: Chondrogenic Cells (14 days)
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ulations24. To generate OS cells, MSC cultures were switched after 1
week to complete osteogenic media containing high glucose
DMEM, 10% v/v FBS, 50 mg/L ascorbic acid, 10 mM b-glycer-
ophosphate, 108 M dexamethasone, and 1% v/v PSF 6 days
immediately prior to hydrogel encapsulation31.
Bilayered hydrogel composite fabrication and MSC encapsulation
Bilayered hydrogel composites comprising separate sub-
chondral and chondral layers were fabricated from sterile reagents
using a two-step crosslinking method27,32. The subchondral layer
was ﬁrst prepared by partially crosslinking the subchondral pre-
cursor mixture within a mold, followed by the complete cross-
linking of the chondral precursor mixture on top to permit
lamination of the two hydrogel layers. Speciﬁcally, 100 mg of OPF
and 50 mg of poly(ethylene glycol) diacrylate (PEG-DA, Mn 3,400 g/
mol; Laysan, Arab, AL) were both dissolved in 300 mL of PBS and
combined with 110 mL of swollen GMP solution. Equal parts
(46.8 mL) of the thermal radical initiator solutions, 0.3 M of
ammonium persulfate (Sigma Aldrich) and 0.3 M of N,N,N0,N0ete-
tramethylethylenediamine (Sigma Aldrich) were then added to the
polymer solution to initiate crosslinking. The respective cell sus-
pension (6.7million cells in 168 mL of PBS) of either MSCs or OS cells
was then added in order to obtain a ﬁnal concentration of 10
million cells permL. After gentlemixing, the subchondral precursor
solution was quickly injected to ﬁll the bottom two-thirds of a cy-
lindrical Teﬂonmold (2.0 mm in diameter and 2.0 mm in thickness)
and incubated at 37C for 5 min to permit partial crosslinking.
Meanwhile, similar precursor solution for the chondral layer was
prepared with MSCs or CG cells. The chondral precursor solution
was then quickly added on top of the partially crosslinked sub-
chondral hydrogel. The resulting bilayered hydrogel constructs
were incubated at 37C for 10 min to complete the crosslinking
reaction. For each animal, bilayered hydrogels were aseptically
transferred in serum-free GM and implanted into osteochondral
defects within 2 h after fabrication. The ﬁnal dimensions of the cell-
laden hydrogel implants after swelling were 3 mm in diameter and3 mm in height, which match the dimensions of osteochondral
defects that were created.
Animal surgery
A total of twenty-four skeletally mature, male 6-month old New
Zealand White rabbits were utilized in the creation of a full-
thickness, bilateral osteochondral defect model based on well-
established studies from our laboratory and others17,19,27,32. The
number of defects, and hence animals used, was determined by
power analysis and in consideration of previous in vivo studies
applying the same model27,32. Anesthesia was induced before sur-
gery by the subcutaneous injection of Ketamine (25e40mg/kg) and
Acepromazine (1e2 mg/kg) and then general anesthesia was
maintained via the ventilator administration of a mixture of iso-
ﬂurane and oxygen.
Critical-sized osteochondral defects (3 mm in diameter and
3 mm in depth) were created in the medial femoral condyles under
irrigation using a dental drill. Prefabricated hydrogel implants were
then press-ﬁtted into the defect site. Subsequently, the patella was
repositioned and the skin and joint capsule were closed. This pro-
cedurewas repeated for both knees for each animal, with each knee
receiving an implant of the same formulation to control for
potentially confounding systemic effects. Each animal received two
hydrogel implants for a total of 12 repetitions (n ¼ 12) for each
experimental group.
To minimize discomfort, Carprofen (4 mg/kg) was administered
for 3 days postoperatively. All animals were returned to their cages
where they were allowed unrestricted weight-bearing activity and
were observed for signs of pain, infection, and proper activity.
Tissue processing
After 12 weeks, rabbits were euthanized by intravenous
administration of Beuthanasia (0.22 mL/kg). Afterward, the tissue
surrounding the medial femoral condyle was retrieved en bloc.
After gross examination, the retrieved specimens were then ﬁxed
in 10% neutral buffered formalin for no more than 72 h, decalciﬁed
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dehydrated through a series of ethanol baths, and embedded in
parafﬁn. 5 mm thick longitudinal sections were taken from the
center (within the central 1 mm), lateral (within the lateral 1 mm),
and medial (within the medial 1 mm) edges of each defect using a
microtome as previously described27. Sections from each defect
regionwere stainedwith hematoxylin and eosin (H&E), Safranin-O/
Fast Green, and van Gieson's Picrofuchsin.
Histomorphometric evaluation of explants
Histological sections from each location of each joint were
scored blindly and independently by three evaluators (SL, VVM, and
FKK) using a well-established scoring algorithm for osteochondral
tissue repair as described previously27. 11 total parameters were
used to analyze tissue repair for the overall defect as awhole as well
as the individual chondral and subchondral regions (Supplemental
Table S1). The overall defect repair was evaluated for the percent
ﬁlling with newly formed tissue and percent degradation of the
implant. The chondral defect region was evaluated for repair tissue
morphology, thickness, regularity, chondrocyte clustering, and cell/
GAG content. The cell/GAG content of the cartilage tissue imme-
diately adjacent to the defect was also scored to evaluate any
possible degenerative effects from the implant. The subchondral
defect region was examined for quality in new tissue ﬁlling, inte-
gration, and bone morphology.
Statistical analysis
The histological scores (mean ± SD) were analyzed using the
Wilcoxon Ranked Sum Test with clustering of the data to accountFig. 1. Histological sections showing representative osteochondral tissue repair at 12 weeks
Green, (b) H&E, and (c) van Gieson's Picrofuchsin (scale bars: 1000 mm). Images from th
ﬁbrocartilage formation ﬁlling the chondral defect space and ossifying chondrocytes in the
mostly comprised ﬁbrocartilage at the joint surface and hypertrophic cartilage in the subcho
bone-like tissue formation in the chondral defect region, as can be seen by the presence ofor similar bilateral treatments for each animal33 using SAS JMP Pro
v10.0. The effect of implant formulation was also assessed for each
knee joint individually between animals using the same statistical
analyses. A conﬁdence interval of 95% was utilized and differences
were considered signiﬁcant when P < 0.05.
Results
Macroscopic observations and gross tissue response
All rabbits underwent osteochondral surgery and recovered
well. Postoperatively, all twenty-four animals regained mobility
within 1 week and resumed normal movement and behavior
during the 12-week incubation period. Upon tissue retrieval, no
gross signs of swelling, inﬂammation, or infectionwere detected on
the joint surface for all experimental groups (Supplemental
Figure S1aed).
Histological observation
While the morphology of the respective neo-formed bone and
cartilage appeared to vary considerably between experimental
groups, most samples retained moderate to trace amounts of
remaining hydrogel particulates that had not yet fully degraded by
12 weeks (Supplemental Figure S1e).
The newly formed cartilaginous tissue ﬁlling the chondral space
of osteochondral defects for the MSC/MSC control group was
typically thinner than the neighboring native cartilage and retained
poor Safranin-O staining in half of the observed cases [Fig. 1(aec)].
The newly formed cartilage mainly comprised ﬁbrocartilage at the
joint surface and hypertrophic cartilage in the subchondral regionpostoperatively for the MSC/MSC group. Sections were stained with (a) Safranin-O/Fast
is sample (aec), which received a score of 2 for cartilage morphology, showed thin
subchondral defect space. (d) The newly formed cartilage in the osteochondral defect
ndral region (scale bar: 500 mm). (e) One other joint from the MSC/MSC group displayed
f osteocytes in the H&E section (scale bar: 500 mm).
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bone formation in the chondral layer, where a close inspection of
the H&E section revealed the presence of osteocytes [Fig. 1(e)].
Neo-cartilage tissue from the MSC/OS group was typically
thicker when compared to the adjacent healthy cartilage
[Fig. 2(aec)] and comprised a combination of ﬁbrocartilage and
hyaline cartilage with areas of chondrocyte condensation near the
osteochondral interface [Fig. 2(d)]. Samples from 2 of the 12 MSC/
OS joints exhibited high quality articular cartilage regeneration.
Many samples also displayed regions of hypertrophy as indicated
by both enlarged chondrocytes and differential matrix staining in
the chondral defect region [Fig. 2(e)].
The neo-surface tissue morphology of CG14/OS samples ranged
considerably from ﬁbrotic to hyaline [Fig. 3(aed)], with one joint
displaying high quality articular cartilage regeneration. At least 10%
of samples from the CG14/OS group also resulted in complete
disruption of the chondral layer [Fig. 3(e)]. In contrast, the neo-
surface tissue morphology of CG7/OS samples generally ranged
from faintly stained ﬁbrocartilage to more intensely stained hyaline
cartilage. Moreover, samples from 2 of the 12 joint defects achieved
well-integrated articular cartilage regeneration [Fig. 4(aec)] with
zonal chondrocytic arrangement similar to that of the native tissue
[Fig. 4(d)] and displayed no instances of complete surface disrup-
tion. New compact and trabecular bone formation can also be seen
in the subchondral defect regions of more than 50% of the CG7/OS
samples [Fig. 4(e)].
Histomorphometric evaluation
The extent of new tissue ﬁlling in the overall osteochondral
defect and the subchondral regionwas not different when observedFig. 2. Histological sections showing representative osteochondral tissue repair at 12 weeks
Green, (b) H&E, and (c) van Gieson's Picrofuchsin (scale bars: 1000 mm). (d) This sample, whi
which mainly comprised a mixture of ﬁbro- and hyaline cartilage (scale bar: 500 mm). This sa
(e) An example of regional hypertrophy in the chondral portion of the defect from another sa
to the surrounding cartilage (scale bar: 500 mm).from the center, lateral, or medial locations within the defect
(Supplemental Table S2). However, the lateral edge displayed
greater neo-cartilage thickness when compared to both the center
and medial edge. For joint surface regularity, the medial edge
revealed smoother surfaces with fewer ﬁssures when compared to
the center and the lateral edge. Lastly, fewer chondrocyte clusters
were observed at the medial edge as opposed to the center.
Osteochondral defects from all groups achieved greater than
50% ﬁlling with newly formed repair tissue (Table II). Similar de-
grees of implant degradation were achieved for all groups, where
implants were more than 50% degraded for all samples.
For subchondral tissue repair, changing the cellular constituents
of implants did not effect any statistical differences between groups
(Table II). Mean scores for subchondral neo-tissue ﬁlling indicated
that greater than 50% but less than 100% of the subchondral space
was ﬁlled with newly formed tissue. The bone morphology score
distribution for each group revealed that at least 80% of samples
received a score of 1, primarily indicating the presence of ﬁbrous
tissue in conjunctionwith bone [Fig. 5(a)]. Despite lowmorphology
scores, the subchondral neo-tissue integrated completely with the
surrounding trabecular bone for all formulations as indicated by
the mean scores of 3.00 ± 0.00 (Table II).
For cartilage regeneration, the CG7/OS group resulted in
improved neo-cartilage morphology over the CG14/OS group
(Table II). The MSC/OS, CG7/OS, and CG14/OS groups achieved
thicker neo-cartilage repair tissue when compared to the control.
Comparing new joint surface regularity, the MSC/OS and CG14/OS
groups resulted in neo-cartilage with fewer and smaller ﬁssures
when compared to the MSC/MSC group, with MSC/OS samples also
scoring higher than CG7/OS samples. For chondrocyte clustering,
CG14/OS samples displayed less cluster formation than CG7/OS andpostoperatively for the MSC/OS group. Sections were stained with (a) Safranin-O/Fast
ch received a score of 2 for cartilage morphology, displayed thicker cartilage formation,
mple also showed the development of a relatively discernable osteochondral interface.
mple displayed enlarged chondrocytes and differential matrix staining when compared
Fig. 3. Histological sections showing representative osteochondral tissue repair at 12 weeks postoperatively for the CG14/OS group. Sections were stained with (a) Safranin-O/Fast
Green, (b and d) H&E, and (c) van Gieson's Picrofuchsin (scale bars: 1000 mm). (d) This sample, which received a score of 2 for cartilage morphology, showed primarily ﬁbrocartilage
tissue repair with some ﬁbrous tissue formation at the joint surface (scale bar: 500 mm). (e) One example of joint surface disruption in another sample is shown in the H&E section
(scale bar: 500 mm).
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content remained unaffected. A breakdown of the cartilage histo-
logical scores to comparisons between groupswithin the peripheral
edges of each individual knee (left or right), which were more
responsive to treatment then the center location (Supplemental
Table S3), revealed that the differential responses in neo-cartilage
morphology and surface regularity mainly stemmed from the right
knee and left knee, respectively (Table III). Both knees conﬁrmed the
differences observed between groups for neo-cartilage thickness.
The score distribution for cartilage morphology revealed that only
groups containing OS cells in the subchondral layer resulted in
articular cartilage regeneration [Fig. 5(b)]. Furthermore, CG7/OS
implants resulted in the highest percentage of samples exhibiting
articular/hyaline cartilage regeneration at 45.7% when compared to
other groups.
Discussion
The present study demonstrated that the delivery of OS cells via
the subchondral layer of the bilayered implants to osteochondral
defects led to improvements in neo-cartilage thickness and surface
regularity over the control. While addition of CG cells in the
chondral layer of the construct did not further inﬂuence the degree
of cartilage repair, it stimulated amore consistent healing response,
where CG7/OS constructs effected the highest percentage of sam-
ples with articular or hyaline cartilage regeneration. Remarkably,
we found that CG7 cells, when co-delivered with OS cells, stimu-
lated morphologically superior cartilage repair when compared to
CG14 cells. However, neither osteogenic nor chondrogenic pre-
differentiation affected detectable changes in subchondral tissue
repair for this study.From previous ﬁndings, we conﬁrmed that OS cells, when
cultured with undifferentiated MSCs in a bilayered hydrogel
construct, stimulated the chondrogenic differentiation of the latter
likely via paracrine effects24,30,34e36. In a parallel study, CG cells,
when co-cultured with OS cells, displayed enhanced chondrogenic
gene expression for type II collagen and aggrecan as well as
increased GAG production in vitro24. Speciﬁcally, CG7 cells dis-
played synthetic proﬁles with higher GAG-to-collagen ratios when
compared to that of CG14 cells in parallel constructs24 and were
more reﬂective of an immature chondrogenic phenotype37. Hence,
we hypothesized that chondrogenic and osteogenic pre-
differentiation of MSCs prior to their encapsulation within
respective chondral and subchondral layers of a bilayered hydrogel
construct would improve osteochondral tissue repair upon im-
plantation due to their enhanced but nascent phenotypes.
In the current study, MSC/MSC samples exhibited generally poor
cartilage tissue healing, where thin ﬁbrocartilage repair tissues and
missing osteochondral interfaces were often observed. Weak
Safranin-O staining of newly formed ﬁbrocartilage indicated that
undifferentiated MSCs might have stimulated an insufﬁcient heal-
ing response by 12 weeks post-implantation. Although research has
shown that implanted MSCs can act as powerful trophic mediators
of the host healing response38 and can augment the chondrogenic
matrix production of mature chondrocytes39, changes to the syno-
vial ﬂuid during injury can alter the cellular transcription of para-
crine signaling molecules of MSCs, speciﬁcally the up-regulation of
pro-inﬂammatory and angiogenic factors that may complicate
healing40. This plausibly explains the diminished tissue healing
observed from the MSC/MSC group when compared to others.
MSC/OS and CG7/OS samples displaying mainly hyaline or
articular cartilage regeneration also commonly displayed regions of
Fig. 4. Histological sections showing representative osteochondral tissue repair at 12 weeks postoperatively for the CG7/OS group. Sections were stained with (a) Safranin-O/Fast
Green, (b) H&E, and (c) van Gieson's Picrofuchsin (scale bars: 1000 mm). (d) This sample, which received a score of 4 for cartilage morphology, displayed high quality articular
cartilage with columnar arrangement of chondrocytes (scale bars: 1000 mm). (e) This sample also displayed compact and trabecular bone formation in the subchondral defect
regions of the osteochondral defects (scale bars: 1000 mm).
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involving the repaired osteochondral junction. Such chondrogenic
foci formation often indicated growth cartilage that could
encourage articular cartilage regeneration and could be modulated
by treatment41,42. It is also suggested that chondrogenic foci for-
mation and an aligned osteochondral junction can enable the
proper advancement of the subchondral plate during osteochon-
dral tissue repair42,43. Unlike the MSC/MSC samples, CG7/OS and
CG14/OS samples did not display instances of bone-like tissue
formation in the chondral defect region, suggesting that the im-
plantation of CG and OS cells via a bilayered hydrogel construct
allowed the cells to maintain segmentation of the local biochemicalTable II
Mean histological scores for all hydrogel formulations at the center, lateral edge, and me
Histological parameter Mean overall scores
MSC/MSC (12 knees)
Overall defect evaluation
1. Percent ﬁlling with newly formed tissue 2.2 ± 0.4
2. Percent degradation of the implant 2.2 ± 0.4
Subchondral bone evaluation
3. Percent ﬁlling with newly formed tissue 2.2 ± 0.5
4. Subchondral bone morphology 1.3 ± 0.8
5. Extent of new tissue bonding with adjacent bone 3.0 ± 0.0
Cartilage evaluation
6. Morphology of newly formed surface tissue 2.3 ± 0.6
7. Thickness of newly formed cartilage 1.5 ± 0.7b,c,d
8. Joint surface regularity 1.9 ± 0.9b,d
9. Chondrocyte clustering 2.1 ± 0.5
10. Chondrocyte and GAG content of neocartilage 1.8 ± 0.8
11. Chondrocyte and GAG content of adjacent cartilage 2.8 ± 0.4
Values are shown as themean ± the standard deviation. Each group comprised 12 implan
a signiﬁcant difference from the MSC/MSC, MSC/OS, CG7/OS and CS14/OS groups, respecenvironment that is inhibitive toward non-speciﬁc phenotypic
changes and conducive to composite tissue regeneration. However,
increasing the chondrogenic pre-differentiation duration of MSCs
from 7 to 14 days prior to their co-delivery with OS cells resulted in
an adverse effect on cartilage morphology in vivo. While hyper-
trophy of the CG14 cells was expected to be the cause, CG14 cells
from parallel constructs did not actually display any up-regulation
of type X collagen gene expression nor adopt hypertrophic changes
over 28 days in vitro24. In a similar study investigating the effect of
osteogenic pre-differentiation time on the efﬁcacy of MSCs for bone
repair using a rat cranial defect model, it was found that MSCs pre-
differentiated for 4 days resulted in the greatest amount of bonedial edge of the defect 12 weeks postsurgery
MSC/OS (12 knees) CG7/OS (12 knees) CG14/OS (12 knees)
2.2 ± 0.4 2.1 ± 0.5 2.1 ± 0.3
2.2 ± 0.4 2.2 ± 0.5 2.1 ± 0.3
2.1 ± 0.5 2.1 ± 0.6 2.0 ± 0.3
1.3 ± 0.9 1.5 ± 1.0 1.1 ± 0.6
3.0 ± 0.0 3.0 ± 0.0 3.0 ± 0.0
2.4 ± 0.6 2.5 ± 0.6d 2.2 ± 0.5c
2.1 ± 0.6a 1.9 ± 0.8a 1.9 ± 0.6a
2.4 ± 0.8a,c 2.2 ± 0.6b 2.3 ± 1.0a
2.0 ± 0.3d 2.1 ± 0.4d 2.3 ± 0.5b,c
1.9 ± 0.7 1.9 ± 0.7 1.8 ± 0.7
2.6 ± 0.6 2.8 ± 0.5 2.6 ± 0.6
ts in bilateral knee joints from six animals (two each). The letters a, b, c and d indicate
tively.
ab
Fig. 5. Histological score distribution for the new (a) subchondral bone morphology
and the new (b) cartilage tissue morphology.
J. Lam et al. / Osteoarthritis and Cartilage 22 (2014) 1291e13001298formation when compared to 10 and 16 days of pre-differentia-
tion44. This effect was attributed to the high proliferation potential
of early osteogenic cells and the subsequent increase in synthetic
activity of these cells during maturation. The prevalence of less-
intensely stained ﬁbrocartilage, resorbing chondrogenic foci42,Table III
Mean histological scores for cell-laden hydrogel formulations at randomly chosen periph
Histological parameter Left knee scores (24 knees total)
MSC/MSC
(6 knees)
MSC/OS
(6 knees)
CG7/OS
(6 knees)
Overall evaluation
1. 2.2 ± 0.4 2.5 ± 0.6 2.2 ± 0.4
2. 2.3 ± 0.5 2.5 ± 0.6 2.2 ± 0.4
Bone evaluation
3. 2.2 ± 0.8 2.5 ± 0.6 2.0 ± 0.6
4. 1.7 ± 1.0 1.8 ± 1.3 1.3 ± 0.8
5. 3.0 ± 0.0 3.0 ± 0.0 3.0 ± 0.0
Cartilage evaluation
6. 2.5 ± 0.6 2.7 ± 0.8 2.7 ± 0.5
7. 1.3 ± 0.5b 2.2 ± 0.4a 1.8 ± 0.8
8. 2.2 ± 0.8b 3.0 ± 0.0a, c 1.8 ± 0.8b
9. 2.2 ± 0.8 2.0 ± 0.0 1.8 ± 0.4
10. 1.7 ± 0.8 1.8 ± 0.8 2.0 ± 0.6
11. 2.8 ± 0.4 2.8 ± 0.4 2.8 ± 0.4
Values are shown as themean ± the standard deviation. Comparisons weremade between
six animals. The letters a, b, c and d indicate a signiﬁcant difference from the MSC/MSC,and irregular osteochondral junctions observed for the CG14/OS
group suggest that the more mature synthetic proﬁle of a lower
GAG-to-collagen ratio24,35 of CG14 cells may have caused the
diminished cartilage repair. Indeed, such results indicate that the
degree of successful cartilage repair elicited in vivo may not
necessarily be directly proportional to the chondrogenic matura-
tion state of the implanted cell-laden cartilage constructs45.
With regard to subchondral neo-tissue morphology, the range
permitted to each score indicated that a score of 1 be given to new
tissue comprising any amount of ﬁbrous tissue, including the
ﬁbrous encapsulation of remaining hydrogel particulates
commonly observed in all groups. Given the relatively short-term
in vivo implantation period of 12 weeks, the low bone
morphology scores may be more an indication of the repair process
rather than of chronic tissue scarring. Hence, samples that dis-
played ﬁbrous encapsulation consistent with a normal healing
response, which eventually remodels into trabecular bone46, were
also included in this score. The presence of particulates only in the
subchondral region, in addition to the improved cartilage scores at
the peripheral edges as compared to the center, suggest that repair
began from the periphery and migrated inward47. Moreover,
increased shear and compressive forces during ambulation may
have caused faster degradation of the implant near the joint sur-
face, allowing the growth of peripheral repair tissue closing the
defect surface to push the remaining implant material downwards
into the slower growing subchondral defect region.
While the current scoring algorithm allows for assessment of
the individual chondral and subchondral tissues as well as the
whole defect32,48, it may overlook smaller but potentially signiﬁ-
cant changes in extracellular matrix structure and tissue response.
Indeed, the impact of the present study would be greatly improved
with the inclusion of more reﬁned microscopic methodologies
including in vivo biochemical and gene expression analyses,
immunohistochemistry for speciﬁc extracellular matrix markers,
quantitative polarized light microscopy49 for assessment of carti-
lage structure and micro-computed tomography50 for assessment
of bone mineralization. However, such techniques are still experi-
mental and do not yet represent standard assessment tools for
in vivo osteochondral defect repair. Another weakness of the study
was the lack of cell tracking in order to elucidate cell fate after
implantation. Cell tracking was not employed in the present study
given its unclear effects on the nature of the cellular pre-
differentiation scheme used. Lastly, a larger animal model and a
longer implantation period would be necessary in order to fully
assess robust tissue repair.eral edges (medial or lateral) of the defects 12 weeks postsurgery
Right knee scores (24 knees total)
CG14/OS
(6 knees)
MSC/MSC
(6 knees)
MSC/OS
(6 knees)
CG7/OS
(6 knees)
CG14/OS
(6 knees)
2.0 ± 0.0 2.0 ± 0.0 2.2 ± 0.4 2.3 ± 0.5 2.2 ± 0.4
2.0 ± 0.0 2.2 ± 0.4 2.2 ± 0.4 2.3 ± 0.5 2.2 ± 0.4
2.0 ± 0.0 2.2 ± 0.4 2.0 ± 0.6 2.2 ± 0.8 2.0 ± 0.6
1.0 ± 0.0 0.8 ± 0.4 1.5 ± 1.2 2.0 ± 1.6 1.0 ± 0.0
3.0 ± 0.0 3.0 ± 0.0 3.0 ± 0.0 3.0 ± 0.0 3.0 ± 0.0
2.3 ± 0.5 2.0 ± 0.6 2.8 ± 0.6d 3.0 ± 0.9d 2.0 ± 0.0b,c
1.8 ± 0.8 1.5 ± 0.6b 2.7 ± 0.8a 2.2 ± 1.0 1.8 ± 0.8
1.8 ± 1.5 1.7 ± 0.8 2.3 ± 0.5 2.5 ± 0.6 2.5 ± 0.6
2.5 ± 0.6 2.0 ± 0.6 2.0 ± 0.6 2.5 ± 0.6 2.3 ± 0.5
1.8 ± 0.8 1.7 ± 0.8 1.8 ± 0.8 2.0 ± 0.9 1.5 ± 0.6
2.8 ± 0.4 2.8 ± 0.4 2.7 ± 0.5 2.7 ± 0.5 2.7 ± 0.5
groups for the same knee, where each group comprised six unilateral implants from
MSC/OS, CG7/OS and CG14/OS groups, respectively.
J. Lam et al. / Osteoarthritis and Cartilage 22 (2014) 1291e1300 1299In summary, we show that the therapeutic efﬁcacy of MSCs on
cartilage regeneration in osteochondral tissue defects can be
enhanced by chondrogenic and osteogenic pre-differentiation prior
to implantation. Additionally, differences in morphological out-
comes as affected by changes to the chondrogenic pre-
differentiation duration reveal that cell phenotype could be opti-
mized in order to achieve ideal tissue repair. Furthermore, we
present a unique method for the delivery of multiple cell types in
order to achieve local biochemical environments conducive to tis-
sue regeneration while mitigating the non-speciﬁc and dosage
limitations of growth factor therapies.
Author contribution
All authors contributed to either to the conception and design of
the study (JL, AGM, FKK), the acquisition, analysis, and interpreta-
tion of the data (JL, SL, EJL, JET, VVM, RLD JvdB, JAJ, AGM, FKK), and/
or the drafting (JL) and critical revision of the article (JL, SL, VVM,
RLD, JvdB, YT, MEW, JAJ, AGM, FKK). All authors approved the ﬁnal
version for submission. JL (johnny.lam@rice.edu), AGM (mikos@
rice.edu), and FKK (kasper@rice.edu) assume full responsibility
for the integrity of the work outlined in this study.
Role of funding source
This work was supported by the National Institutes of Health (R01
AR048756). The study sponsors had no involvement in the study
design nor the collection, analysis, interpretation of data. The study
sponsors also had no involvement in neither the writing of the
manuscript nor the decision to submit the manuscript for
publication.
Competing interest statement
All authors report no conﬂicts of interest as none of the authors
received any compensation for this work. The authors also do not
hold any ﬁnancial interests that would cause potential conﬂicts of
interest related to this work.
Acknowledgments
We especially thank Natasja van Dijk for her technical expertise
with tissue histology. We would also like to thank the registered
veterinary technicians at the University of Texas Health Science
Center for their support during the animal procedures.
Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.joca.2014.06.035.
References
1. Cheng YJ, Hootman JM, Murphy LB, Langmaid GA, Helmick CG.
Prevalence of doctor-diagnosed arthritis and arthritis-
attributable activity limitation e United States, 2007e2009.
Morb Mortal Wkly Rep 2010;59:1261e5.
2. Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage
defects: study of 25,124 knee arthroscopies. Knee 2007;14:
177e82.
3. Behery O, Siston RA, Harris JD, Flanigan DC. Treatment of
cartilage defects of the knee: expanding on the existing algo-
rithm. Clin J Sport Med 2014;24:21e30.
4. Buschmann MD, Hoemann CD, Hurtig MB, Shive MS. Cartilage
repair with chitosan-glycerol phosphate-stabilized blood clots.
In: Cartilage Repair Strategies. Totowa, New Jersey: Humana
Press; 2007:85e104.5. Gille J, Schuseil E, Wimmer J, Gellissen J, Schulz AP, Behrens P.
Mid-term results of autologous matrix-induced chondro-
genesis for treatment of focal cartilage defects in the knee.
Knee Surg Sports Traumatol Arthrosc 2010;18:1456e64.
6. Kuo AC, Rodrigo JJ, Reddi AH, Curtiss S, Grotkopp E, Chiu M.
Microfracture and bone morphogenetic protein 7 (BMP-7)
synergistically stimulate articular cartilage repair. Osteoar-
thritis Cartilage 2006;14:1126e35.
7. Mithoefer K. Complex articular cartilage restoration. Sports
Med Arthrosc 2013;21:31e7.
8. Micheli LJ, Browne JE, Erggelet C, Fu F, Mandelbaum B,
Moseley JB, et al. Autologous chondrocyte implantation of the
knee: multicenter experience and minimum 3-year follow-up.
Clin J Sport Med 2001;11:223e8.
9. Hennig T, Lorenz H, Thiel A, Goetzke K, Dickhut A, Geiger F,
et al. Reduced chondrogenic potential of adipose tissue derived
stromal cells correlates with an altered TGFbeta receptor and
BMP proﬁle and is overcome by BMP-6. J Cell Physiol
2007;211:682e91.
10. Im GI, Kim DY, Shin JH, Hyun CW, Cho WH. Repair of cartilage
defect in the rabbit with cultured mesenchymal stem cells
from bone marrow. J Bone Joint Surg Br 2001;83:289e94.
11. Qi Y, Zhao T, Xu K, Dai T, Yan W. The restoration of full-
thickness cartilage defects with mesenchymal stem cells
(MSCs) loaded and cross-linked bilayer collagen scaffolds on
rabbit model. Mol Biol Rep 2012;39:1231e7.
12. Shirasawa S, Sekiya I, Sakaguchi Y, Yagishita K, Ichinose S,
Muneta T. In vitro chondrogenesis of human synovium-
derived mesenchymal stem cells: optimal condition and
comparison with bone marrow-derived cells. J Cell Biochem
2006;97:84e97.
13. Tay LX, Ahmad RE, Dashtdar H, Tay KW, Masjuddin T, Ab-
Rahim S, et al. Treatment outcomes of alginate-embedded
allogenic mesenchymal stem cells versus autologous chon-
drocytes for the repair of focal articular cartilage defects in a
rabbit model. Am J Sports Med 2012;40:83e90.
14. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM,
Caplan AI, et al. Mesenchymal cell-based repair of large, full-
thickness defects of articular cartilage. J Bone Joint Surg Am
1994;76:579e92.
15. Wang Y, Kim UJ, Blasioli DJ, Kim HJ, Kaplan DL. In vitro carti-
lage tissue engineering with 3D porous aqueous-derived silk
scaffolds and mesenchymal stem cells. Biomaterials 2005;26:
7082e94.
16. Yan H, Yu C. Repair of full-thickness cartilage defects with cells
of different origin in a rabbit model. Arthroscopy 2007;23:
178e87.
17. Anderson JA, Little D, Toth AP, Moorman 3rd CT, Tucker BS,
Ciccotti MG, et al. Stem cell therapies for knee cartilage repair:
the current status of preclinical and clinical studies. Am J Sports
Med 2013, http://dx.doi.org/10.1177/0363546513508744
(Epub ahead of print).
18. Chang CH, Kuo TF, Lin FH, Wang JH, Hsu YM, Huang HT, et al.
Tissue engineering-based cartilage repair with mesenchymal
stem cells in a porcine model. J Orthop Res 2011;29:
1874e80.
19. Guo X, Park H, Young S, Kretlow JD, van den Beucken JJ,
Baggett LS, et al. Repair of osteochondral defects with biode-
gradable hydrogel composites encapsulating marrow mesen-
chymal stem cells in a rabbit model. Acta Biomater 2010;6:
39e47.
20. Tang QO, Carasco CF, Gamie Z, Korres N, Mantalaris A,
Tsiridis E. Preclinical and clinical data for the use of mesen-
chymal stem cells in articular cartilage tissue engineering.
Expert Opin Biol Ther 2012;12:1361e82.
J. Lam et al. / Osteoarthritis and Cartilage 22 (2014) 1291e1300130021. Zscharnack M, Hepp P, Richter R, Aigner T, Schulz R,
Somerson J, et al. Repair of chronic osteochondral defects using
predifferentiated mesenchymal stem cells in an ovine model.
Am J Sports Med 2010;38:1857e69.
22. Dashtdar H, Rothan HA, Tay T, Ahmad RE, Ali R, Tay LX, et al.
A preliminary study comparing the use of allogenic chondro-
genic pre-differentiated and undifferentiated mesenchymal
stem cells for the repair of full thickness articular cartilage
defects in rabbits. J Orthop Res 2011;29:1336e42.
23. Grayson WL, Bhumiratana S, Grace Chao PH, Hung CT, Vunjak-
Novakovic G. Spatial regulation of human mesenchymal stem
cell differentiation in engineered osteochondral constructs:
effects of pre-differentiation, soluble factors and medium
perfusion. Osteoarthritis Cartilage 2010;18:714e23.
24. Lam J, Lu S, Meretoja VV, Tabata Y, Mikos AG, Kasper FK.
Generation of osteochondral tissue constructs with chon-
drogenically and osteogenically predifferentiated mesen-
chymal stem cells encapsulated in bilayered hydrogels. Acta
Biomater 2014;10:1112e23.
25. Kinard LA, Kasper FK, Mikos AG. Synthesis of oligo(poly(-
ethylene glycol) fumarate). Nat Protoc 2012;7:1219e27.
26. Lam J, Kim K, Lu S, Tabata Y, Scott DW, Mikos AG, et al.
A factorial analysis of the combined effects of hydrogel fabri-
cation parameters on the in vitro swelling and degradation of
oligo(poly(ethylene glycol) fumarate) hydrogels. J Biomed
Mater Res A 2013, http://dx.doi.org/10.1002/jbm.a.35015
(Epub ahead of print).
27. Kim K, Lam J, Lu S, Spicer PP, Lueckgen A, Tabata Y, et al.
Osteochondral tissue regeneration using a bilayered com-
posite hydrogel with modulating dual growth factor release
kinetics in a rabbit model. J Control Release 2013;168:
166e78.
28. Holland TA, Tabata Y, Mikos AG. In vitro release of trans-
forming growth factor-beta 1 from gelatin microparticles
encapsulated in biodegradable, injectable oligo(poly(ethylene
glycol) fumarate) hydrogels. J Control Release 2003;91:
299e313.
29. Holland TA, Tessmar JK, Tabata Y, Mikos AG. Transforming
growth factor-beta 1 release from oligo(poly(ethylene glycol)
fumarate) hydrogels in conditions that model the cartilage
wound healing environment. J Control Release 2004;94:
101e14.
30. Guo X, Liao J, Park H, Saraf A, Raphael RM, Tabata Y, et al. Ef-
fects of TGF-beta3 and preculture period of osteogenic cells on
the chondrogenic differentiation of rabbit marrow mesen-
chymal stem cells encapsulated in a bilayered hydrogel com-
posite. Acta Biomater 2010;6:2920e31.
31. Guo X, Park H, Liu G, Liu W, Cao Y, Tabata Y, et al. In vitro
generation of an osteochondral construct using injectable
hydrogel composites encapsulating rabbit marrow mesen-
chymal stem cells. Biomaterials 2009;30:2741e52.
32. Holland TA, Bodde EW, Cuijpers VM, Baggett LS, Tabata Y,
Mikos AG, et al. Degradable hydrogel scaffolds for in vivo de-
livery of single and dual growth factors in cartilage repair.
Osteoarthritis Cartilage 2007;15:187e97.
33. Bryant D, Havey TC, Roberts R, Guyatt G. How many patients?
How many limbs? Analysis of patients or limbs in the ortho-
paedic literature: a systematic review. J Bone Joint Surg Am
2006;88A:41e5.
34. Rothenberg AR, Ouyang L, Elisseeff JH. Mesenchymal stem cell
stimulation of tissue growth depends on differentiation state.
Stem Cells Dev 2011;20:405e14.
35. Chen WH, Lai MT, Wu AT, Wu CC, Gelovani JG, Lin CT, et al.
In vitro stage-speciﬁc chondrogenesis of mesenchymal stemcells committed to chondrocytes. Arthritis Rheum 2009;60:
450e9.
36. Thibault RA, Mikos AG, Kasper FK. Protein and mineral
composition of osteogenic extracellular matrix constructs
generated with a ﬂow perfusion bioreactor. Bio-
macromolecules 2011;12:4204e12.
37. Williamson AK, Chen AC, Sah RL. Compressive properties and
function-composition relationships of developing bovine
articular cartilage. J Orthop Res 2001;19:1113e21.
38. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic me-
diators. J Cell Biochem 2006;98:1076e84.
39. Wu L, Leijten JC, Georgi N, Post JN, van Blitterswijk CA,
Karperien M. Trophic effects of mesenchymal stem cells in-
crease chondrocyte proliferation and matrix formation. Tissue
Eng Part A 2011;17:1425e36.
40. Vezina Audette R, Lavoie-Lamoureux A, Lavoie JP, Laverty S.
Inﬂammatory stimuli differentially modulate the transcription
of paracrine signaling molecules of equine bone marrow
multipotent mesenchymal stromal cells. Osteoarthritis Carti-
lage 2013;21:1116e24.
41. Chen H, Chevrier A, Hoemann CD, Sun J, Lascau-Coman V,
Buschmann MD. Bone marrow stimulation induces greater
chondrogenesis in trochlear vs condylar cartilage defects in
skeletally mature rabbits. Osteoarthritis Cartilage 2013;21:
999e1007.
42. Chevrier A, Hoemann CD, Sun J, Buschmann MD. Temporal and
spatial modulation of chondrogenic foci in subchondral
microdrill holes by chitosan-glycerol phosphate/blood im-
plants. Osteoarthritis Cartilage 2011;19:136e44.
43. Qiu YS, Shahgaldi BF, Revell WJ, Heatley FW. Observations of
subchondral plate advancement during osteochondral repair:
a histomorphometric and mechanical study in the rabbit
femoral condyle. Osteoarthritis Cartilage 2003;11:810e20.
44. Castano-Izquierdo H, Alvarez-Barreto J, van den Dolder J,
Jansen JA, Mikos AG, Sikavitsas VI. Pre-culture period of
mesenchymal stem cells in osteogenic media inﬂuences their
in vivo bone forming potential. J Biomed Mater Res A 2007;82:
129e38.
45. Fisher MB, Henning EA, Soegaard NB, Dodge GR, Steinberg DR,
Mauck RL. Maximizing cartilage formation and integration via
a trajectory-based tissue engineering approach. Biomaterials
2014;35:2140e8.
46. Holland TA, Bodde EWH, Baggett LS, Tabata Y, Mikos AG,
Jansen JA. Osteochondral repair in the rabbit model utilizing
bilayered, degradable oligo(poly(ethylene glycol) fumarate)
hydrogel scaffolds. J BiomedMaterResPartA2005;75A:156e67.
47. Brun P, Dickinson SC, Zavan B, Cortivo R, Hollander AP,
Abatangelo G. Characteristics of repair tissue in second-look
and third-look biopsies from patients treated with engi-
neered cartilage: relationship to symptomatology and time
after implantation. Arthritis Res Ther 2008;10:R132.
48. Orth P, Zurakowski D, Wincheringer D, Madry H. Reliability,
reproducibility, and validation of ﬁve major histological
scoring systems for experimental articular cartilage repair in
the rabbit model. Tissue Eng Part C Methods 2012;18:329e39.
49. Raub CB, Hsu SC, Chan EF, Shirazi R, Chen AC, Chnari E, et al.
Microstructural remodeling of articular cartilage following
defect repair by osteochondral autograft transfer. Osteoar-
thritis Cartilage 2013;21:860e8.
50. Chang NJ, Lam CF, Lin CC, Chen WL, Li CF, Lin YT, et al.
Transplantation of autologous endothelial progenitor cells in
porous PLGA scaffolds create a microenvironment for the
regeneration of hyaline cartilage in rabbits. Osteoarthritis
Cartilage 2013;21:1613e22.
